Stocks to Watch Tomorrow
Fresh order wins, strategic partnerships and a key European regulatory approval could keep Coal India, Srivasavi Adhesive Tapes and Lupin in the spotlight on Thursday.
✨ Key Takeaways
Indian equity benchmarks ended higher on Wednesday, July 1, with the Nifty 50 reclaiming the 24,000 mark after two consecutive sessions of losses. Strong June sales data from automobile companies boosted investor sentiment, although weakness in information technology stocks and lingering geopolitical concerns limited gains.
Also Read - Mahindra Group-Backed Auto Company Tops Nifty 50 as June Sales Beat Street Estimates
The Nifty 50 settled at 24,005.85, up 0.59 per cent, while the Sensex advanced 440.10 points, or 0.58 per cent, to close at 76,922.64.
Against this backdrop, several stocks are expected to remain in focus during Thursday's trading session following key corporate announcements.
Coal India Ltd informed exchanges that it has received a Letter of Award from Bundelkhand Saur Urja Limited for setting up a 600 MW Solar power project at Jalaun Solar Park in Uttar Pradesh. The project comprises two units of 300 MW each and has been awarded at a tariff of Rs 2.73 per kWh. The estimated project cost is Rs 2,831.11 crore.
The company said the project is expected to be executed within 18 months from the signing of the Power Purchase Agreement (PPA). As part of the award conditions, Coal India will be required to submit necessary documents, pay upfront solar park development charges and execute the relevant agreements before commencing implementation.
The order has been awarded by a domestic entity and marks another step in Coal India's efforts to strengthen its presence in the renewable energy sector.
2. Srivasavi Adhesive Tapes Ltd
Srivasavi Adhesive Tapes Ltd announced that its Polymer Division (Unit 5), located at Sompura Industrial Area in Bengaluru Rural, has entered into a purchasing agreement with a global multinational company. The agreement, executed on July 1, 2026, formalises Srivasavi Adhesive Tapes as a manufacturing supplier of polypropylene (PP), high-density polyethylene (HDPE), fabric and related products to the multinational company.
The development is expected to strengthen the company's customer base and expand its presence in the industrial and packaging materials segment.
3. Lupin Ltd
Lupin Ltd said the European Medicines Agency (EMA) has approved a change to the terms of marketing authorisation for NaMuscla, a treatment used for non-dystrophic myotonic disorders.
The approval includes the addition of two new dosage strengths — 62 mg and 83 mg capsules — alongside the existing 167 mg strength.
The revised authorisation also expands the indication to cover symptomatic treatment of myotonia in children aged 6 to 11 years weighing at least 20 kg, adolescents aged 12 to 17 years and adults aged 18 years and above.
The regulatory approval was supported by the Pediatric Investigation Plan and is expected to broaden patient access to the therapy across Europe, strengthening Lupin's specialty pharmaceutical portfolio in the region.
Disclaimer: The article is for informational purposes only and not investment advice.
